Virginia Retirement Systems’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-35,000
Closed -$553K 1147
2018
Q2
$553K Buy
35,000
+100
+0.3% +$1.75K 0.01% 874
2018
Q1
$600K Buy
34,900
+11,700
+50% +$228K 0.01% 792
2017
Q4
$509K Sell
23,200
-6,700
-22% -$215K 0.01% 805
2017
Q3
$1.22M Sell
29,900
-10,500
-26% -$330K 0.01% 611
2017
Q2
$1.22M Buy
40,400
+100
+0.2% +$3.12K 0.02% 608
2017
Q1
$1.46M Buy
40,300
+13,600
+51% +$599K 0.02% 555
2016
Q4
$1.34M Sell
26,700
-1,200
-4% -$63K 0.02% 520
2016
Q3
$1.46M Buy
27,900
+1,400
+5% +$66.9K 0.02% 462
2016
Q2
$1.1M Buy
+26,500
New +$1.15M 0.02% 545

Other funds holding FPRX

Virginia Retirement Systems's FPRX Position: Q3 2018 in Review

Virginia Retirement Systems sold out of Five Prime Therapeutics, Inc. (FPRX) in Q3 2018, closing a stake of 35,000 shares — an estimated $553K sold.

Virginia Retirement Systems first reported a position in FPRX in Q2 2016 and held it in 9 quarters. The position peaked at $1.46M in Q3 2016. 114 funds tracked by Wall St. Rank hold FPRX as of Q3 2018.

  • Virginia Retirement Systems reported no remaining Five Prime Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
  • Virginia Retirement Systems sold 35,000 Five Prime Therapeutics, Inc. shares in Q3 2018, an estimated $553K.
  • Virginia Retirement Systems first reported a position in Five Prime Therapeutics, Inc. in Q2 2016 and held it in 9 quarters.
  • Virginia Retirement Systems's Five Prime Therapeutics, Inc. position peaked at $1.46M in Q3 2016.
  • 114 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q3 2018.

Based on Virginia Retirement Systems's 13F filing for Q3 2018, filed 2 Nov 2018.